These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4594755)

  • 1. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 4. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lactulose in the treatment of portacaval encephalopathy].
    Meoni GC
    Clin Ter; 1971 Oct; 59(1):59-67. PubMed ID: 5157287
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
    Girard PF; Trillet M; Kopp N
    Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
    Eisenburg J; Krumpoch B; Grunst J; Weinzierl M; Munte A; Schmidt S; Magerl W; Schauer S
    Fortschr Med; 1972 Aug; 90(24):837-48. PubMed ID: 4639347
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lactulose in the therapy of porto-systemic encephalopathy].
    Almici C; Inzoli MR; Poloni AE; Zambruni A
    Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lactulose in the treatment of chronic portosystemic encephalopathies].
    Seidlová V
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
    [No Abstract]   [Full Text] [Related]  

  • 12. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 14. Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.
    Rorsman G; Sulg I
    Acta Med Scand; 1970 May; 187(5):337-46. PubMed ID: 5526951
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)].
    Cassi E; Sala E; Beretta R; Colombo A; Cova L; Ezechieli S; Malacco E; Massarotti G; Pagani C
    Clin Ter; 1972 Dec; 63(6):531-56. PubMed ID: 4656204
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of total colectomy in portacaval encephalopathy].
    Leger L; Lenriot JP; Fourestier M; Goiffon B
    J Chir (Paris); 1972; 103(5):437-50. PubMed ID: 4653423
    [No Abstract]   [Full Text] [Related]  

  • 17. [The blood ammonia electroencephalogram pattern in the evaluation of portosystemic encephalopathy].
    Bataller Sifre R; López Gómez LJ; Abella Llácer A; Berto Navarro R; González Marrtínez M
    Rev Esp Enferm Apar Dig; 1972 Feb; 36(3):293-304. PubMed ID: 5058815
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactulose treatment of hepatic encephalopathy in outpatients.
    Brown H; Trey C; McDermott WV
    Arch Surg; 1971 Jan; 102(1):25-7. PubMed ID: 5538764
    [No Abstract]   [Full Text] [Related]  

  • 20. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
    Bircher J; Haemmerli UP; Williams R
    Gastroenterology; 1970 Apr; 58(4):595-7. PubMed ID: 5438009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.